C. Thompson

Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis

J. Epstein, G. Kenet, D. Nugent, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.